Microfluidic Device for Rare Cell Enrichment and Viability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating rare cells, such as circulating tumor cells, face challenges due to low abundance and fragility, resulting in low capture efficiency and variability in reproducibility, making them unsuitable for subsequent molecular analyses and clinical applications.
Innovation Solution
A microfluidic device with a non-fouling composition is used to selectively enrich rare cells, maintaining at least 40% viability during capture and release, and employing a foam composition with air bubbles to detach target cells from a lipid bi-layer surface, allowing for efficient and viable cell recovery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional isolation techniques (immuno-magnetic isolation, cell-size based filtration, antibody-functionalized microfluidic devices) are used to capture rare cells, then capture efficiency is improved, but cell viability and reproducibility deteriorate
Solution Approach 1:
The device segments the capture process into distinct functional zones: a first capture surface with high-affinity antibodies for initial rare cell enrichment, followed by a second capture surface with lower-affinity antibodies for further purification. This segmentation allows progressive enrichment while maintaining cell integrity and reducing non-specific binding effects that plague conventional single-step methods.
Solution Approach 2:
The patent introduces an intermediary washing step between the first and second capture surfaces. This intermediary process removes non-specifically bound cells and debris before the second capture phase, thereby improving reproducibility and reducing false positives without sacrificing the high capture efficiency achieved in the first phase.
2Measurement precision
If rare cells are captured using conventional methods, then detection sensitivity is improved, but cell integrity for subsequent molecular analysis deteriorates
Solution Approach 1:
The patent replaces harsh mechanical isolation methods (such as vigorous vortexing, high-speed centrifugation, or forceful elution) with gentle physiological elution conditions. Cells are released using buffered solutions at physiological pH and temperature, maintaining cell membrane integrity and intracellular component stability for subsequent molecular analyses while still achieving high detection sensitivity.
Solution Approach 2:
The patent utilizes parameter changes in the elution buffer (pH, ionic strength, temperature) to selectively release captured cells from the antibody-coated surface. By optimizing these parameters, the device achieves high cell recovery with maintained viability and integrity, enabling downstream applications like PCR, sequencing, or single-cell analysis that require intact cellular material.
3Measurement precision
If capture efficiency is increased to detect low-abundance rare cells, then diagnostic accuracy is improved, but non-specific binding and false positives increase
Solution Approach 1:
The segmented two-stage capture approach allows differential optimization: the first surface uses high-affinity antibodies for sensitive detection of rare cells, while the second surface uses lower-affinity antibodies that reduce non-specific binding. This segmentation enables diagnostic accuracy to be maintained through the first stage while the second stage filters out false positives.
Solution Approach 2:
The patent employs partial action by using multiple antibody types with different affinities across two surfaces rather than a single excessive-affinity antibody layer. This partial approach to capture (distributed across two surfaces) reduces the non-specific binding problems that arise from using excessively high-affinity single-layer captures, while maintaining diagnostic accuracy through the cumulative effect of both stages.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high capture efficiency and viability of rare cells, enabling accurate analysis and clinical utility in cancer diagnosis, prognosis, and treatment by ensuring the integrity and viability of isolated cells for further molecular analysis.
Implementation Method 1
employing a foam composition with air bubbles to detach target cells from a lipid bi-layer surface
Implementation Method 2
flowing air foam across the microfluidic surface... detaching the top layer, thereby releasing the target cells
Data Source
AI summary
The disclosure provides for compositions and methods of making and using a foam composition and its utility in clinical applications.